Provider Alert! Nasonex

Provider Alert!

Provider Alert! Nasonex

Effective July 27, 2017, Nasonex will be reclassified from preferred to non-preferred. Fluticasone nasal will be the only preferred intranasal corticosteroid for allergic rhinitis. Patients requiring Nasonex on or after July 27, 2017 will require a prior authorization.

Prior authorization forms can be found here:

Questions? Please contact Navitus at 1-877-908-6023.

Share this post

Leave a Reply